NCT02604550

Anterior Cruciate Ligament Pain Study

Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 115 (actual)
• Sponsor: Emory University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Detailed description

This trial is a prospective, randomized, surgeon-blinded, two-armed trial to investigate the safety and efficacy of femoral nerve blocks versus adductor canal blocks for participants undergoing outpatient anterior cruciate ligament (ACL) reconstruction surgery. The objective of this study is to compare the pain control benefit of two different types of nerve blocks. Ropivacaine, which is FDA-approved for use in both femoral nerve blocks as well as adductor canal blocks, will be utilized. The study will be comparing the efficacy between FDA approved treatments.

Conditions

• Anterior Cruciate Ligament Reconstruction

Interventions

Type	Name	Description
DRUG	Ropivacaine 0.5%	Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.
DRUG	Percocet 7.5/325	Percocet 7.5/325 will taken as needed up to every four hours.
DRUG	Naprosyn 500 mg	Naprosyn 500 mg will be taken twice daily.

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-04-01
• Completion: 2016-04-01
• First posted: 2015-11-13
• Last updated: 2017-05-31
• Results posted: 2017-05-31

Locations

1 site across 1 country: United States